Program
- Theme
- - Performance Evaluation of High-Cost Drugs Based on Real-World Data (RWD)
- Main contents
- - Examples and Achievements of Using Real-World Data: Methods of utilizing Real-World Data in high-cost innovative pharmaceuticals and the resulting achievements.
- - Experiences and Challenges of Using Real-World Data: The journey and challenges of building, managing, and utilizing Real-World Data, and how to overcome them.
- - Real-World Data Governance: Management systems, committees, and partnerships for managing Real-World Data.
| Time (KST) |
Session | Speaker |
| 10:00~ 10:30 |
Registration | |
| < Openeing Session > | ||
| 10:30~ 10:45 |
Opeining Remarks | · President of HIRA |
| Group Photos | ||
| 10:45~ 11:15 |
Keynote Speech 1 | · Vandana Ayyar Gupta (UK, Scientific Advisor of National Institute for Health and Care Excellence) – Making Real-World Evidence Work for Better Decision Making at NICE |
| 11:15~ 11:45 |
Keynote Speech 2 | · Soyoung Yi (Republic of Korea, Director General of Pharmaceutical Performance Assessment Department of HIRA) – RWD-Driven Collaboration for Sustainable Access to High-Cost Medicines |
| < Session 1> | ||
| 11:45~ 13:00 |
Lunch | |
| 13:00~ 13:30 |
Presentation 1 | · Bor-Sheng Ko (Taiwan, Professor of National Taiwan University Cancer Center) – Utilizing RWD/RWE to Reimburse High-Cost Medicine: Experiences and Challenges in Taiwan |
| 13:30~ 14:00 |
Presentation 2 | · Nicole Mittmann (Canada, Vice President of Canada’s Drug Agency) – Real-World Evidence for Decision-Making about High-Cost Drugs |
| 14:00~ 14:40 |
Panel Discussion | · Moderator: Yoonsoo Park (Republic of Korea, Chair of the Subcommittee for Economic Feasibility Evaluation of HIRA) · Panel: Dokhyun Yoon (Republic of Korea, Associate Professor of Oncology of Seoul Asan Medical Center) Eun-a Han (Republic of Korea, Professor of College of Pharmacy of Yonsei University) Soyoung Yi (Republic of Korea, Director General of Pharmaceutical Performance Assessment Department of HIRA) Bor-Sheng Ko (Taiwan, Professor of National Taiwan University Cancer Center) Nicole Mittmann (Canada, Vice President of Canada’s Drug Agency) |
| 14:40~ 15:00 |
Break | |
| < Session 2> | ||
| 15:00~ 15:30 |
Presentation 3 | · Jatin K. Dave (USA, Professor of University of Massachusetts Chan Medical School) – Balanced Approach to Pharmaceutical Coverage: Focusing on Outcome-based Contracting and Real-World Data |
| 15:30~ 16:00 |
Presentation 4 | · Claus Møldrup (Denmark, Director of Data Analytics Center of Danish Medicines Agency) – Big Data Better Drugs |
| 16:00~ 16:40 |
Panel Discussion |
· Moderator: Jungsin Lee · Panel: Eunju Lee (Republic of Korea, Deputy Director of Pharmaceutical Benefits Division of Ministry of Health and Welfare) |
| 16:40~ | Closing | |
※ Details such as schedule, topic, and speaker (discussant) are subject to change depending on the event conditions.
Health Insurance Review and Assessment Service(HIRA)
60 HYEOKSIN-RO, WONJU-SI, GANGWON-STATE(BANGOK-DONG) 26465, KOREA / TEL. +82-2-1644-2000
Agency Omni Management. Co., Ltd.
(Corporate Registration No. 806-88-01176) 811, Ryuma Tower2, 59-17, Magokjungang-ro, Gangseo-gu, Seoul, Korea / TEL. +82-2-2667-0030
Health Insurance Review and Assessment Service(HIRA)
(26465) 60 HYEOKSIN-RO, WONJU-SI, GANGWON-STATE(BANGOK-DONG) 26465, KOREA / TEL. 1644-2000
Agency Omni Management. Co., Ltd.
(Corporate Registration No. 806-88-01176)
811, Ryuma Tower2, 59-17, Magokjungang-ro, Gangseo-gu, Seoul, Korea / TEL. 02-2667-0030